Prof. Jacques Demongeot, University Grenoble Alpes, France

Prof. Jacques Demongeot is a renowned French academic with an exceptional career blending applied mathematics and medical science. As an Honorary Member of the Institut Universitaire de France, he has held influential positions including President of the European Society for Mathematical and Theoretical Biology and the Société Francophone de Biologie Théorique. He is affiliated with University Joseph Fourier in Grenoble and the AGEIS Laboratory, focusing on biomedical informatics, theoretical biology, and smart healthcare technologies. Prof. Demongeot’s work is highly interdisciplinary, bridging mathematics, biology, and clinical applications. Over the decades, he has significantly contributed to areas such as health smart homes, predictive modeling, and Boolean networks, with a prolific record of peer-reviewed publications and international collaborations. His research is not only deeply theoretical but also highly impactful for public health systems and patient care. His influence spans across generations of researchers and across continents, cementing his legacy as a transformative scholar.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

🎓 Interdisciplinary Excellence:
Prof. Demongeot uniquely holds a Ph.D. in Applied Mathematics and an M.D. in Medicine, positioning him as a rare and influential figure in computational medicine and mathematical biology.
📚 Outstanding Publication Record:
With hundreds of peer-reviewed publications in prestigious journals, his research spans from health informatics to genetic modeling and non-linear systems—highlighting both depth and breadth.
🌍 International Recognition and Collaboration:
Former President of major scientific boards such as the European Society for Mathematical and Theoretical Biology, his leadership has shaped research agendas globally.
🏥 Innovation in Smart Health & Telemedicine:
He has contributed significantly to the development of smart home technologies and e-health systems for elderly care—translating science into societal impact.
🧠 Theoretical Contributions with Practical Value:
His work integrates modeling, biological systems theory, and real-world medical applications, especially in chronic disease management and health monitoring systems.

🛠️ Areas for Improvement:

📢 Broader Public Engagement:
While his academic influence is undisputed, increasing visibility through public science communication and media outreach could expand the societal resonance of his work.
👨‍🏫 Mentorship Visibility:
More explicit focus on his role as a mentor and research supervisor (e.g., Ph.D. students trained, junior faculty supported) would highlight his contribution to academic continuity.
🌐 Centralized Digital Presence:
A consolidated digital portfolio (website or research repository) could enhance accessibility to his full body of work for interdisciplinary audiences and policy-makers.

🎓 Education:

Jacques Demongeot’s educational background reflects his deep-rooted expertise in both mathematical theory and clinical science. He earned his Ph.D. in Applied Mathematics in 1975 from the University Joseph Fourier of Grenoble, where he specialized in mathematical modeling and systems theory. Demonstrating his dual commitment to both scientific rigor and human health, he completed his Doctorate in Medicine (M.D.) in 1978 from the same institution. This rare combination of qualifications provided him with the analytical tools of a mathematician and the practical understanding of a medical doctor. It positioned him uniquely to pioneer interdisciplinary approaches in systems biology, bioinformatics, and smart health systems. His educational achievements laid the foundation for a long and impactful career bridging numerical theory and real-world healthcare challenges. This dual expertise has enabled him to lead innovative research in diverse domains, from wound healing modeling to the design of telemedicine tools and aging-related medical support technologies.

💼 Experience:

Prof. Jacques Demongeot’s professional career spans over four decades of academic excellence, leadership, and innovation. As a professor at the Faculty of Medicine at the University J. Fourier of Grenoble, he has led pioneering research in mathematical biology and biomedical engineering. He served as President of CIMES (1994–1998), President of the French CNU 46-04 (1994–2000), and President of the European Society for Mathematical and Theoretical Biology (1998–2000). Additionally, he was President of the Société Francophone de Biologie Théorique from 2006 to 2014. He has played pivotal roles in establishing research programs in smart homes for elderly care, medical imaging technologies, and non-linear biological systems modeling. Prof. Demongeot has also contributed to international journals, research boards, and multi-national scientific initiatives. His career combines deep theoretical insight with hands-on application and societal impact, marking him as a rare blend of thought leader, mentor, and innovator.

🔬 Research Focus:

Prof. Jacques Demongeot’s research focuses on mathematical and theoretical biology, with extensive work in functional statistics, telemedicine, health smart homes, genetic code modeling, and Boolean automata networks. His work bridges the gap between abstract modeling and applied biomedical engineering. He has designed predictive models for chronic diseases, including diabetes and obesity, and has contributed to understanding biological regulation, cell differentiation, and wound healing through discrete mesh and morphogenetic modeling. He also investigates social and network-based approaches to frailty and aging. Additionally, Prof. Demongeot has led the development of sensor networks and telemedicine platforms for home-based patient monitoring. His research often uses non-linear systems, stochastic modeling, and functional data analysis, making significant contributions to both clinical and public health informatics. His integrative approach connects human physiology, healthcare infrastructure, and computational biology—enabling a holistic understanding of health across biological, social, and technological domains.

📚 Publications Top Notes:

1️⃣ 📊 Relative-Error Prediction in Nonparametric Functional Statistics: Theory and Practice
2️⃣ 📉 Estimation locale linéaire de la fonction de régression pour des variables hilbertiennes
3️⃣ 🧠 Global Regulation of Individual Decision Making
4️⃣ 🖼️ Comparison of the Evolution and Entropy of Responses on an Absurdum Questionnaire
5️⃣ 🏠 Smart homes: data fusion for preventive and therapy education at home
6️⃣ 🧬 Poitiers school of mathematical and theoretical biology: RNA structures and genetic code
7️⃣ 🦓 Wound healing modelling in Zebrafish
8️⃣ 🌱 Discrete mesh approach in morphogenesis: the example of gastrulation
9️⃣ 📈 Local linear regression modelization when all variables are curves
🔟 👴 Estimation of life expectancy of cancer patients in Valparaiso Region

🏁 Conclusion:

Prof. Jacques Demongeot is exceptionally well-qualified for the Best Academic Researcher Award. His interdisciplinary achievements, pioneering contributions to biomedical engineering and mathematical biology, and global academic leadership make him a model candidate. His body of work demonstrates a seamless blend of theoretical innovation and real-world medical application—impacting both science and society. With enhanced visibility and strategic outreach, his influence could become even more profound across generations and disciplines.

Lijuan Deng | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Posted on 15/04/202515/04/2025 by Cell Biologist

Mrs. Lijuan Deng | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Mrs. Lijuan Deng , Zhongshan Institute for Drug Discovery , China

Lijuan Deng is a passionate graduate student researcher at the Zhongshan Institute for Drug Discovery in China, specializing in the molecular mechanisms underlying metabolic diseases. Her scientific curiosity centers on gene regulation, signaling pathways, and metabolic dysregulation in disease progression, particularly metabolic-associated fatty liver disease (MASLD). Her translational approach blends experimental models and bioinformatics to bridge basic science and therapeutic innovation. Lijuan has already co-authored a publication in The FASEB Journal, identifying CDKN1A as a key regulator in MASLD. She is also the inventor of a patent-pending technique for nascent RNA labeling in extracellular vesicles. Through collaborations with clinical researchers and a solid foundation in molecular biology techniques, she is positioning herself as a rising talent in cell biology. Her work promises to advance understanding and treatment of metabolic diseases.

Publication Profile:

Orcid

✅ Strengths for the Award:

Innovative Research: Lijuan Deng has significantly contributed to the understanding of MASLD (Metabolic-Associated Steatotic Liver Disease) by identifying CDKN1A as a key regulatory gene through integrated transcriptomic analysis and experimental validation.
Translational Focus: Her research bridges molecular biology and clinical application, enhancing its impact in drug discovery and disease diagnostics.
Publication Record: She is the first author of a peer-reviewed article published in The FASEB Journal (SCI-indexed), showcasing her ability to conduct and communicate high-quality research.
Patent Innovation: She holds a pending patent for a novel method involving nascent RNA labeling in extracellular vesicles, showing her drive toward technological advancement and biomedical innovation.
Collaborative Approach: Active collaboration with the Department of Endocrinology at Shenzhen Second People’s Hospital reflects strong interdisciplinary and clinical integration.

🧩 Areas for Improvement:

Expanded Publication Portfolio: Increasing the number of peer-reviewed articles will strengthen her academic visibility and impact.
Professional Networking: Engagement in international cell biology societies or conferences and obtaining professional memberships can support broader recognition and growth.
Editorial/Leadership Roles: Participation in editorial boards, review panels, or student leadership roles can enrich her professional development profile.

🎓 Education:

Lijuan Deng is currently pursuing her graduate studies in molecular biology at the Zhongshan Institute for Drug Discovery, where she focuses on translational biomedical research. Her academic foundation includes advanced coursework in biochemistry, molecular genetics, and cellular signaling. Through structured academic training, she has acquired proficiency in modern laboratory methods, including RNA sequencing, qPCR, western blotting, and exosome analysis. Her education emphasizes critical thinking and scientific rigor, enabling her to design experiments, analyze data, and interpret biological outcomes. She regularly participates in academic seminars, journal clubs, and collaborative workshops to refine her scientific acumen. Her thesis research is centered around identifying novel molecular targets in MASLD, a field gaining global relevance. Lijuan’s education is not only shaping her technical capabilities but also nurturing her ambition to contribute to impactful, real-world medical solutions through cell biology research.

💼 Experience:

Lijuan Deng has gained extensive laboratory experience as a graduate student researcher at the Zhongshan Institute for Drug Discovery. Her hands-on work includes both cellular and animal models, with a strong focus on metabolic disease mechanisms. She played a key role in identifying CDKN1A as a potential MASLD progression factor, combining transcriptomic data analysis with molecular validation. Additionally, she has worked on exosome-based biomarker discovery and developed a patent-pending method for nascent RNA labeling. She collaborates with the Department of Endocrinology at Shenzhen Second People’s Hospital, providing a clinical dimension to her work. Though early in her career, her contributions to translational research are already making an impact. She is skilled in molecular biology, gene expression profiling, and therapeutic target screening. Her research experience has been shaped by interdisciplinary collaboration, scientific publications, and the ambition to innovate within the field of molecular cell biology.

🧬 Research Focus:

Lijuan Deng’s research is primarily focused on the molecular underpinnings of metabolic-associated fatty liver disease (MASLD), a key manifestation of metabolic syndrome. She investigates how dysregulated genes, signaling networks, and lipid metabolism contribute to disease initiation and progression. A major highlight of her work is identifying CDKN1A as a potential risk factor in MASLD using integrated bioinformatics and experimental techniques. Additionally, she explores the utility of extracellular vesicles as carriers of diagnostic biomarkers and therapeutic molecules. Her patent-pending work involves a novel method for labeling nascent RNA within exosomes, opening possibilities for tracking dynamic RNA communication in disease contexts. Her research strategy merges molecular biology with disease modeling, aiming to bridge laboratory discoveries with potential therapeutic strategies. Through strong collaborations and a translational research outlook, Lijuan is dedicated to uncovering actionable insights that can inform drug development for complex metabolic disorders.

📚 Publications Top Notes:

🧾 “Identification of CDKN1A as a potential key risk factor in MASLD progression.” – The FASEB Journal, 2025. DOI: 10.1096/fj.202402942R

🧾 Conclusion:

Lijuan Deng stands out as an emerging researcher with strong foundations in molecular cell biology and a clear orientation toward translational science. Her innovative work in MASLD, combined with an SCI publication and a pending patent, make her a highly suitable and promising candidate for the Molecular Cell Biology Award. While she is in the early stages of her career, her achievements thus far indicate substantial potential for future contributions to the field.

Zhirong Tan | Gene Regulation Epigenetics | Best Researcher Award

Posted on 15/04/202515/04/2025 by Cell Biologist

Prof. Zhirong Tan | Gene Regulation Epigenetics | Best Researcher Award

Prof. Zhirong Tan , Xiangya Hospital, Central South University , China

Professor Zhirong Tan is a leading Chinese expert in pharmacogenomics and clinical pharmacology. Currently a professor at Xiangya Hospital, Central South University, he also serves as the Director of the Pharmacogenetics and Pharmacokinetics Research Laboratory and Deputy Director of the Drug Analysis Center. He has been instrumental in over 300 clinical trials, pushing forward the frontiers of precision medicine, especially in colorectal cancer and Alzheimer’s disease. With over 20 SCI papers, multiple patents, and co-authorship of four books, he’s widely recognized for his work in pharmacokinetics and biomarker discovery. A national GCP and GMP inspector, Prof. Tan actively contributes to pharmaceutical regulation and innovation in China. His academic and industry partnerships reflect a robust foundation in translational research and real-world drug development.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

Extensive Research Contributions
Prof. Zhirong Tan has made outstanding contributions to clinical pharmacology, pharmacogenetics, and metabolomics over two decades. His research has provided critical insights into drug metabolism, biomarker discovery, and precision medicine, especially in colorectal cancer and Alzheimer’s disease.
Prolific Publication Record
With over 22 SCI-indexed publications (first or corresponding author) and 6 CSCD papers, Prof. Tan’s research has achieved over 3550 citations and an H-index of 33 on Web of Science—evidence of the high impact and recognition of his work.
Strong National & Industry Collaborations
He has participated in or led 300+ clinical trials and secured 5 “Million+” industry-funded projects, reflecting strong ties with both academia and industry. His leadership in national-level projects, such as the “Major New Drug Development” program, showcases his influence in China’s healthcare innovation.
Intellectual Property and Innovation
With 3 granted patents and 3 under review, Prof. Tan’s ability to translate research into practical applications is evident. His individualized esomeprazole dosing regimen highlights innovation at the clinical level.
Regulatory & Policy Contributions
As a national GCP/GMP inspector, he plays a pivotal role in drug trial ethics and compliance in China. He also holds leadership roles in pharmacogenomics committees, further demonstrating his commitment to public health advancement.
Academic Mentorship and Editorial Work
In addition to research, Prof. Tan contributes as a journal reviewer, co-author of four textbooks, and mentor to the next generation of scientists, reinforcing his role as a thought leader in the field.

🔍 Areas for Improvement:

International Visibility
While Prof. Tan’s national presence is remarkable, further international collaborations, invited keynotes at global conferences, or leading roles in global consortia could enhance his visibility and expand the influence of his work.
Broader Publication Range
Publishing more frequently in top-tier international journals (e.g., Nature, The Lancet, NEJM) would increase the global academic reach of his findings.
Open Science & Data Sharing
As the field moves toward transparency, incorporating open-access publications and shared data repositories could boost both reproducibility and citations.

🎓 Education:

Professor Zhirong Tan obtained his Ph.D. from Central South University, a premier Chinese institution, where he laid the groundwork for his expertise in clinical pharmacology and pharmacogenomics. He later pursued postdoctoral research at the School of Pharmacy, University of Maryland, Baltimore, one of the top pharmaceutical research institutions in the United States. This international experience enabled him to gain a global perspective in drug metabolism, biomarker identification, and translational pharmacology. His academic training focused on cutting-edge methodologies such as metabolomics, pharmacokinetics, and precision medicine. Through continuous education and research, he has built a reputation as a highly skilled pharmacologist whose work bridges basic research and clinical applications.

💼 Experience:

With a research career spanning over two decades since 1998, Professor Zhirong Tan has led and participated in numerous national-level and provincial-level projects, including China’s National Science and Technology Major Projects. He currently holds multiple leadership positions at Xiangya Hospital, Central South University. Over the years, he has completed major research grants from NSFC, the Hunan Province, and the Ministry of Science and Technology. As a GCP and GMP inspector, Prof. Tan has overseen more than 300 clinical trials, ensuring drug development meets regulatory and ethical standards. His experience also extends to industry collaboration, with successful execution of 5 “Million+” funded projects and influential roles in pharma-academic alliances. A frequent peer reviewer and contributor to international journals, his work influences both the scientific community and regulatory frameworks.

🔬 Research Focus:

Professor Tan’s primary research focus lies in clinical pharmacology, pharmacogenomics, and metabolomics, particularly for colorectal cancer and Alzheimer’s disease. His work aims to identify and validate biomarkers for disease diagnosis, drug efficacy, and toxicity prediction. A major contributor to China’s “Major New Drug Development” initiative, he has developed personalized esomeprazole dosing regimens by studying genetic polymorphisms, SNPs, and microRNA interactions. His research also explores the pathogenesis of Alzheimer’s disease using metabolomic profiling, offering insights into early detection and potential therapeutics. He applies advanced bioanalytical methods to understand inter-individual variability in drug metabolism and therapeutic response. His projects have real-world clinical implications, transforming how drugs are prescribed, regulated, and monitored. Through his pioneering work, Prof. Tan contributes significantly to the evolution of precision medicine in China.

📚 Publication Top Notes:

📊 Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males
❤️ Gly389Arg polymorphism of β1‐adrenergic receptor and cardiovascular response to metoprolol
💊 CYP2C19 ultra-rapid metabolizer genotype affects voriconazole pharmacokinetics
🧬 HLA‐B35:01 allele as biomarker for Polygonum multiflorum–induced liver injury*
🌿 Repeated berberine administration inhibits cytochromes P450 in humans
💉 Effect of SLCO1B1 polymorphism on pharmacokinetics of nateglinide
🧪 Assessment of cytochrome P450 activity by five‐drug cocktail approach
☕ Plasma caffeine metabolite ratio linked to CYP1A2 polymorphisms
🔬 Inducibility of CYP1A2 by omeprazole associated with genetic polymorphism
🧫 Ile118Val polymorphism of CYP3A4 affects simvastatin lipid-lowering efficacy

📝 Conclusion:

Professor Zhirong Tan is a highly deserving candidate for the Best Researcher Award. His record of scientific excellence, clinical innovation, and regulatory leadership clearly positions him as a key contributor to modern pharmacology. His integrated approach—spanning basic science, clinical trials, and health policy—has had a measurable impact on patient care and drug development in China.

While there is room to further expand his global footprint, his accomplishments to date already demonstrate the caliber, commitment, and consistency expected of a world-class researcher.

Weili Miao | RNA biology | Best Researcher Award

Posted on 19/03/202519/03/2025 by Cell Biologist

Dr. Weili Miao | RNA biology | Best Researcher Award

Dr. Weili Miao , Stanford , United States

Weili Miao is an accomplished postdoctoral researcher at Stanford University specializing in molecular biology and biochemistry. He obtained his Ph.D. in Chemistry from the University of California, Riverside in 2019 and holds a B.S. in Chemistry from Fudan University, China. Miao’s research integrates biochemistry, proteomics, and genomics to explore novel biomolecular interactions in the context of epidermal differentiation, RNA-protein interactions, and DNA-protein interactions. His work has significantly contributed to the understanding of glucose’s role in cellular regulation, as well as in uncovering new molecular mechanisms related to gene expression and differentiation. Miao has published extensively in high-impact journals and has received recognition for his contributions to the field of molecular biology, particularly regarding glucose-protein interactions and RNA regulation.

Publication Profile:

Google Scholar

Strengths for the Award:

Weili Miao is an exceptional candidate for the “Best Researcher Award” due to his groundbreaking contributions to the field of molecular biology. His research has provided crucial insights into biomolecular interactions, particularly in the context of glucose-protein, RNA-protein, and DNA-protein interactions. His postdoctoral research at Stanford University has led to the discovery of novel roles for glucose in regulating epidermal differentiation, including glucose’s interaction with key proteins like DDX21, DDX50, and NSUN2. Miao’s ability to integrate advanced techniques like MST, easy-CLIP, and PROBER into his work shows his innovative approach to solving complex biological questions. His prolific publication record in top-tier journals, such as Cell, Nature Communications, and Cell Reports, further highlights his ability to make significant contributions to molecular biology.

Areas for Improvements:

While Miao’s research focus has been diverse and impactful, one area for improvement could be to expand his studies to include more clinical or translational applications. This would enable his findings to have more direct implications for disease treatment or therapeutic interventions. Additionally, increasing his collaboration with clinical researchers and expanding his research network could help bring practical solutions to real-world problems.

Education:

Weili Miao holds a Ph.D. in Chemistry from the University of California, Riverside, where he completed his doctoral research in 2019. During his time at UCR, he honed his skills in chemical biology, proteomics, and molecular research. His academic journey began with a Bachelor of Science in Chemistry from Fudan University, one of China’s leading universities, where he developed a solid foundation in chemical analysis and molecular science. Miao’s education has equipped him with advanced research techniques in proteomics, molecular signaling, and biomolecular interactions, which he continues to apply in his postdoctoral work at Stanford University. His ability to combine cutting-edge technologies and experimental methodologies has enabled him to explore complex biological systems, making him a strong contributor to his research community.

Experience:

Weili Miao’s research experience spans several years, with a focus on biomolecular interactions and their implications in cellular differentiation and gene expression. He is currently a postdoctoral researcher at Stanford University, where he investigates novel functions of glucose-protein, RNA-protein, and DNA-protein interactions. His work has led to breakthroughs in understanding how glucose regulates protein interactions that influence epidermal differentiation. Miao has utilized various advanced technologies such as microscale thermophoresis (MST), easy-CLIP, and PROBER to study protein-RNA and protein-DNA interactions. Prior to his postdoctoral position, he completed a Ph.D. at UC Riverside, where he explored targeted proteomic approaches and studied the AMP-binding capacities of kinases. Miao has also contributed to multiple publications in high-impact journals, showcasing his ability to lead and collaborate on groundbreaking research projects. His work continues to shape the understanding of molecular processes in cellular biology.

Awards and Honors:

Weili Miao has received several prestigious awards and honors in recognition of his outstanding research contributions. He was awarded the K01 NIH Mentored Research Scientist Development Award in 2024, supporting his work as a principal investigator in the next phase of his research career. Additionally, Miao received the UCR Dissertation Year Program Fellowship in 2018-2019, which allowed him to complete his doctoral studies with distinguished achievement. In 2019, he was recognized with the Award for Chinese Outstanding Self-financed Students Abroad, which acknowledges exceptional academic and research accomplishments. These honors highlight Miao’s dedication to advancing the field of molecular biology and his exceptional ability to tackle complex scientific challenges. His recognition by these prestigious institutions underscores his potential to continue making significant contributions to biomedical research.

Research Focus:

Weili Miao’s research focuses on understanding the molecular mechanisms underlying cellular differentiation, gene expression, and interactions between biomolecules such as glucose, RNA, and DNA. At Stanford University, Miao’s postdoctoral work has identified novel functions of glucose-protein interactions, particularly how glucose binds proteins like DDX21, DDX50, and NSUN2 to regulate epidermal differentiation. His research also incorporates cutting-edge methods such as microscale thermophoresis (MST) to analyze protein interactions, easy-CLIP for RNA-protein interactions, and PROBER for DNA-protein interactions. Miao’s work is significant for its potential impact on therapeutic strategies for diseases related to gene expression and cellular differentiation. His multidisciplinary approach integrates proteomics, genomics, and biochemistry to explore how cellular processes are regulated at the molecular level, with the goal of identifying new molecular targets for disease intervention and improving our understanding of human biology.

Publication Top Notes:

“Disease-Linked Regulatory DNA Variants and Homeostatic Transcription Factors in Epidermis” 🔬💉 (Nat. Commun., under revision)
“DDX50 cooperates with STAU1 to effect stabilization of pro-differentiation RNAs” 🧬⚡ (Cell Rep., 2025)
“Glucose binds and activates NSUN2 to promote translation and epidermal differentiation” 🍬💪 (Nucleic Acids Res., 2024)
“Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation” 🍩🔧 (Cell, 2023)
“Targeted Proteomic Approaches for Proteome-wide Characterizations of the AMP-binding Capacities of Kinases” 🧪🧬 (J. Proteome Res., 2022)
“Quantitative Proteomic Analysis Revealed Broad Roles of N6-Methyladenosine in Heat Shock Response” 🔬🔥 (J. Proteome Res., 2021)
“Kinome Reprogramming During Radiation Resistance Acquisition in Breast Cancer Cells” 🧪💥 (J. Proteome Res., 2021)
“SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity” 🦠🔬 (Lancet Infect. Dis., 2021)
“A Targeted Quantitative Proteomic Method Revealed Substantial Reprogramming of Kinome during Melanoma Metastasis” 🧬🌱 (Sci. Rep., 2020)

Conclusion:

In conclusion, Weili Miao is an exemplary researcher whose work continues to shape our understanding of cellular biology at a molecular level. His dedication to uncovering novel molecular mechanisms, as well as his use of cutting-edge technologies, positions him as a strong candidate for the Best Researcher Award. With continued innovation and a broader focus on clinical translation, Miao’s work is poised to make a lasting impact on both the scientific community and therapeutic fields.

Wahiduzzaman Emon | RNA Biology Function | Best Researcher Award

Posted on 27/12/202427/12/2024 by Cell Biologist

Mr. Wahiduzzaman Emon | RNA Biology Function | Best Researcher Award

Mr. Wahiduzzaman Emon , Aix Marseille University , France

Wahiduzzaman Emon is a promising researcher in the field of optics, photonics, and biosensing. Currently pursuing a Joint M.Sc in Optics & Photonics through the Erasmus Mundus Europhotonics program, he is studying at Aix Marseille University, France, and Tampere University, Finland. Emon has a strong academic background with a B.Sc. in Electrical and Electronic Engineering from Ahsanullah University of Science & Technology, Bangladesh. With numerous awards, including an Erasmus Mundus scholarship and the Dean’s List Award, he has demonstrated exceptional skills in research. Emon’s work is primarily focused on developing advanced biosensors using surface plasmon resonance (SPR), plasmonic materials, and 2D materials for applications in cancer detection and environmental monitoring. His research contributions are well-recognized through multiple publications in prestigious journals and conferences.

Publication Profile:

Google Scholar

Strengths for the Award:

Wahiduzzaman Emon is a highly accomplished researcher with exceptional academic performance and technical expertise in optics, photonics, and biosensors. His work on advanced plasmonic biosensors, particularly using photonic crystal fibers (PCFs) for cancer detection and bacterial diagnostics, demonstrates innovative thinking and a strong capacity for impactful research. He has published multiple papers in respected journals and conferences, and his contributions to designing novel biosensors for healthcare applications show great promise in both academic and practical contexts. His research is not only technically rigorous but also socially relevant, aiming to improve diagnostics in cancer and infectious diseases.

Areas for Improvement:

While Emon’s research is impressive, expanding his network and increasing international collaborations can further enhance his visibility and the impact of his work. Additionally, diversifying his research into more interdisciplinary fields could offer broader insights into emerging technologies. Working on scaling his designs from theoretical models to prototype stages could also enhance the real-world applicability of his innovations.

Education:

Wahiduzzaman Emon is currently enrolled in a Joint M.Sc in Optics & Photonics under the prestigious Erasmus Mundus Europhotonics program. He is studying at Aix Marseille University in France and Tampere University in Finland from September 2024 to 2026. Before this, he completed his B.Sc. in Electrical and Electronic Engineering at Ahsanullah University of Science & Technology in Dhaka, Bangladesh, where he achieved a CGPA of 3.848/4.00, ranking in the top 5% of his class. His undergraduate thesis focused on a highly sensitive ZnO/Ag/BaTiO3/MoS2 hybrid structure-based surface plasmon biosensor for detecting Mycobacterium tuberculosis. This solid educational foundation has laid the groundwork for his deep interest and excellence in the fields of optics, photonics, and biosensing technologies, paving the way for his future success in cutting-edge research.

Experience:

Wahiduzzaman Emon has gained valuable research experience through multiple projects and collaborations. As a Research Assistant in the Department of Electrical and Electronic Engineering at Ahsanullah University of Science & Technology, Bangladesh, from May to August 2024, he contributed significantly to researching surface plasmon resonance (SPR)-based sensors for cancer and chemical detection. He co-supervised undergraduate theses on sensor development and conducted extensive simulations. His research experience also includes designing advanced photonic crystal fibers (PCF) for communication and sensing applications, including significant work on CT-PCF design for enhanced birefringence and nonlinearity, published in several conferences. In addition, Emon worked on the development of SPR biosensors for detecting cancerous cells in collaboration with Taif University, Saudi Arabia. His extensive use of COMSOL Multiphysics, MATLAB, and OriginPro for modeling and simulations has enhanced his expertise in biosensors and photonic devices.

Awards and Honors:

Wahiduzzaman Emon’s academic journey has been marked by several prestigious awards and honors. He was awarded the Erasmus Mundus Scholarship for his Joint M.Sc in Optics & Photonics from September 2024 to 2026, a highly competitive award that recognizes exceptional international talent. In his undergraduate studies, Emon was consistently recognized for his academic excellence, earning the Dean’s List Award for outstanding performance at Ahsanullah University of Science & Technology, Dhaka, Bangladesh, from 2020 to 2024. He was also named the Champion of the Final Year Thesis Project competition in May 2024, where his thesis on plasmonic biosensors outperformed other projects in the Electronics department. These accolades underscore Emon’s academic abilities and his potential for contributing significantly to the fields of photonics, biosensing, and optical sciences.

Research Focus:

Wahiduzzaman Emon’s research primarily focuses on the development of advanced biosensors, with particular interest in surface plasmon resonance (SPR), plasmonic materials, and 2D materials. His work aims to enhance the sensitivity and specificity of biosensors for applications in cancer detection, tuberculosis diagnosis, and environmental monitoring. Emon’s research in photonic crystal fibers (PCF) explores their use in improving optical communication systems and developing plasmonic biosensors. He has designed multi-layered SPR sensors for cancer cell detection and explored novel materials such as ZnO/Ag/BaTiO3/MoS2 hybrid structures to improve biosensor performance. By combining computational tools like COMSOL Multiphysics and MATLAB, Emon is working on creating innovative solutions to increase the efficiency and reliability of biosensing devices. His contributions to photonics, biosensors, and plasmonics have the potential to make significant impacts on healthcare and environmental monitoring.

Publications Top Notes:

W. Emon, M. F. Nayan, S. Salehin, A. Chaki, S. Tuba, K. M. Ishtiak, “Highly sensitive ZnO/Ag/BaTiO3/MoS2 hybrid structure-based surface plasmon biosensor for the detection of mycobacterium tuberculosis bacteria,” Optics Continuum, vol. 3, no. 3, pp. 495-512, 2024. 🌟
W. Emon, A. Chaki, T. P. Mondal, M. D. F. Nayan, R. R. Mahmud, “Photonic crystal fiber-based SPR biosensor coated with Ag-TiO2 and Au-TiO2 for the detection of skin cancer: a comparison,” Optical and Quantum Electronics, vol. 56, no. 8, article 1322, 2024. 🧬
W. Emon, A. Chaki, F. K. Nahian, M. D. F. Nayan, R. R. Mahmud, “Performance Analysis of Ag-TiO2-Coated Hexagonal-Shaped Photonic Crystal Fiber Plasmonic Sensor and Ethanol’s Low Water Content Detection,” Plasmonics, pp. 1-13, 2024. 🔬
S. A. Rafi, W. Emon, A. A. Rafsan, R. R. Mahmud, M. F. Nayan, M. M. A. Eid, “Optical Based Surface Plasmon Resonance Sensor for the Detection of the Various Kind of Cancerous Cell,” Cell Biochemistry and Biophysics, pp. 1-27, 2024. 🧪
A. Halder, W. Emon, M. S. Anower, M. R. Tanshen, M. Forkan, M. S. U. Shajib, “Design and numerical analysis of ultra-high negative dispersion, highly birefringent nonlinear single mode core-tune photonic crystal fiber (CT-PCF) over communication bands,” Optics and Photonics Journal, vol. 13, no. 10, pp. 227-242, 2023. 🌐

Conclusion:

Given his academic achievements, research excellence, and dedication to advancing photonic technologies, Wahiduzzaman Emon is a highly deserving candidate for the Best Researcher Award. His innovative contributions, especially in the design of biosensors, make him an excellent representative of cutting-edge research in optics and photonics.